Global RNA-Based Therapeutics and Vaccines Market Insights, Forecast to 2028

Report ID: 1655145 | Published Date: Apr 2026 | No. of Page: 113 | Base Year: 2025 | Rating: 4.7
Request Sample Report
Pre-Order Enquiry 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 RNA-Based Therapeutics
        1.2.3 RNA-Based Vaccines
    1.3 Market by Application
        1.3.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Immunology
        1.3.4 Ophthalmology
        1.3.5 Cardiovascular Diseases
        1.3.6 Infectious Diseases
        1.3.7 Genetic Diseases
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2017-2028)
    2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Region
        2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 RNA-Based Therapeutics and Vaccines Market Dynamics
        2.3.1 RNA-Based Therapeutics and Vaccines Industry Trends
        2.3.2 RNA-Based Therapeutics and Vaccines Market Drivers
        2.3.3 RNA-Based Therapeutics and Vaccines Market Challenges
        2.3.4 RNA-Based Therapeutics and Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue
        3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2017-2022)
        3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
    3.4 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
        3.4.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2021
    3.5 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
    3.6 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
    3.7 Date of Enter into RNA-Based Therapeutics and Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Based Therapeutics and Vaccines Breakdown Data by Type
    4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2023-2028)
5 RNA-Based Therapeutics and Vaccines Breakdown Data by Application
    5.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    6.2 North America RNA-Based Therapeutics and Vaccines Market Size by Type
        6.2.1 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
        6.2.2 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028)
        6.2.3 North America RNA-Based Therapeutics and Vaccines Market Share by Type (2017-2028)
    6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Application
        6.3.1 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
        6.3.2 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028)
        6.3.3 North America RNA-Based Therapeutics and Vaccines Market Share by Application (2017-2028)
    6.4 North America RNA-Based Therapeutics and Vaccines Market Size by Country
        6.4.1 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
        6.4.2 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    7.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type
        7.2.1 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
        7.2.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028)
        7.2.3 Europe RNA-Based Therapeutics and Vaccines Market Share by Type (2017-2028)
    7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Application
        7.3.1 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
        7.3.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028)
        7.3.3 Europe RNA-Based Therapeutics and Vaccines Market Share by Application (2017-2028)
    7.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Country
        7.4.1 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
        7.4.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type
        8.2.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Share by Type (2017-2028)
    8.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application
        8.3.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Share by Application (2017-2028)
    8.4 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region
        8.4.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    9.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Type
        9.2.1 Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
        9.2.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028)
        9.2.3 Latin America RNA-Based Therapeutics and Vaccines Market Share by Type (2017-2028)
    9.3 Latin America RNA-Based Therapeutics and Vaccines Market Size by Application
        9.3.1 Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
        9.3.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028)
        9.3.3 Latin America RNA-Based Therapeutics and Vaccines Market Share by Application (2017-2028)
    9.4 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country
        9.4.1 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
        9.4.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type
        10.2.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Share by Type (2017-2028)
    10.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application
        10.3.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Share by Application (2017-2028)
    10.4 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country
        10.4.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Alnylam Pharmaceuticals
        11.1.1 Alnylam Pharmaceuticals Company Details
        11.1.2 Alnylam Pharmaceuticals Business Overview
        11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.1.5 Alnylam Pharmaceuticals Recent Developments
    11.2 Arbutus Biopharma
        11.2.1 Arbutus Biopharma Company Details
        11.2.2 Arbutus Biopharma Business Overview
        11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
        11.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.2.5 Arbutus Biopharma Recent Developments
    11.3 Arrowhead Pharmaceuticals
        11.3.1 Arrowhead Pharmaceuticals Company Details
        11.3.2 Arrowhead Pharmaceuticals Business Overview
        11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.3.5 Arrowhead Pharmaceuticals Recent Developments
    11.4 BioNTech
        11.4.1 BioNTech Company Details
        11.4.2 BioNTech Business Overview
        11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
        11.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.4.5 BioNTech Recent Developments
    11.5 CureVac
        11.5.1 CureVac Company Details
        11.5.2 CureVac Business Overview
        11.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
        11.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.5.5 CureVac Recent Developments
    11.6 Dicerna Pharmaceuticals
        11.6.1 Dicerna Pharmaceuticals Company Details
        11.6.2 Dicerna Pharmaceuticals Business Overview
        11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.6.5 Dicerna Pharmaceuticals Recent Developments
    11.7 Regulus Therapeutics
        11.7.1 Regulus Therapeutics Company Details
        11.7.2 Regulus Therapeutics Business Overview
        11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
        11.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.7.5 Regulus Therapeutics Recent Developments
    11.8 Marina Biotech
        11.8.1 Marina Biotech Company Details
        11.8.2 Marina Biotech Business Overview
        11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
        11.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.8.5 Marina Biotech Recent Developments
    11.9 MiRagen Therapeutics
        11.9.1 MiRagen Therapeutics Company Details
        11.9.2 MiRagen Therapeutics Business Overview
        11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
        11.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.9.5 MiRagen Therapeutics Recent Developments
    11.10 Moderna Therapeutics
        11.10.1 Moderna Therapeutics Company Details
        11.10.2 Moderna Therapeutics Business Overview
        11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
        11.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.10.5 Moderna Therapeutics Recent Developments
    11.11 Quark Pharmaceuticals
        11.11.1 Quark Pharmaceuticals Company Details
        11.11.2 Quark Pharmaceuticals Business Overview
        11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.11.5 Quark Pharmaceuticals Recent Developments
    11.12 Roche
        11.12.1 Roche Company Details
        11.12.2 Roche Business Overview
        11.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
        11.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.12.5 Roche Recent Developments
    11.13 Sylentis
        11.13.1 Sylentis Company Details
        11.13.2 Sylentis Business Overview
        11.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
        11.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.13.5 Sylentis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of RNA-Based Therapeutics
    Table 3. Key Players of RNA-Based Vaccines
    Table 4. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global RNA-Based Therapeutics and Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global RNA-Based Therapeutics and Vaccines Market Share by Region (2017-2022)
    Table 8. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global RNA-Based Therapeutics and Vaccines Market Share by Region (2023-2028)
    Table 10. RNA-Based Therapeutics and Vaccines Market Trends
    Table 11. RNA-Based Therapeutics and Vaccines Market Drivers
    Table 12. RNA-Based Therapeutics and Vaccines Market Challenges
    Table 13. RNA-Based Therapeutics and Vaccines Market Restraints
    Table 14. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global RNA-Based Therapeutics and Vaccines Revenue Share by Players (2017-2022)
    Table 16. Global Top RNA-Based Therapeutics and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2021)
    Table 17. Ranking of Global Top RNA-Based Therapeutics and Vaccines Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by RNA-Based Therapeutics and Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
    Table 21. Date of Enter into RNA-Based Therapeutics and Vaccines Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2017-2022)
    Table 25. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2023-2028)
    Table 27. Global RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global RNA-Based Therapeutics and Vaccines Revenue Share by Application (2017-2022)
    Table 29. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global RNA-Based Therapeutics and Vaccines Revenue Share by Application (2023-2028)
    Table 31. North America RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Alnylam Pharmaceuticals Company Details
    Table 62. Alnylam Pharmaceuticals Business Overview
    Table 63. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
    Table 64. Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 65. Alnylam Pharmaceuticals Recent Developments
    Table 66. Arbutus Biopharma Company Details
    Table 67. Arbutus Biopharma Business Overview
    Table 68. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product
    Table 69. Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 70. Arbutus Biopharma Recent Developments
    Table 71. Arrowhead Pharmaceuticals Company Details
    Table 72. Arrowhead Pharmaceuticals Business Overview
    Table 73. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
    Table 74. Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 75. Arrowhead Pharmaceuticals Recent Developments
    Table 76. BioNTech Company Details
    Table 77. BioNTech Business Overview
    Table 78. BioNTech RNA-Based Therapeutics and Vaccines Product
    Table 79. BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 80. BioNTech Recent Developments
    Table 81. CureVac Company Details
    Table 82. CureVac Business Overview
    Table 83. CureVac RNA-Based Therapeutics and Vaccines Product
    Table 84. CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 85. CureVac Recent Developments
    Table 86. Dicerna Pharmaceuticals Company Details
    Table 87. Dicerna Pharmaceuticals Business Overview
    Table 88. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
    Table 89. Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 90. Dicerna Pharmaceuticals Recent Developments
    Table 91. Regulus Therapeutics Company Details
    Table 92. Regulus Therapeutics Business Overview
    Table 93. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product
    Table 94. Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 95. Regulus Therapeutics Recent Developments
    Table 96. Marina Biotech Company Details
    Table 97. Marina Biotech Business Overview
    Table 98. Marina Biotech RNA-Based Therapeutics and Vaccines Product
    Table 99. Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 100. Marina Biotech Recent Developments
    Table 101. MiRagen Therapeutics Company Details
    Table 102. MiRagen Therapeutics Business Overview
    Table 103. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product
    Table 104. MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 105. MiRagen Therapeutics Recent Developments
    Table 106. Moderna Therapeutics Company Details
    Table 107. Moderna Therapeutics Business Overview
    Table 108. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product
    Table 109. Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 110. Moderna Therapeutics Recent Developments
    Table 111. Quark Pharmaceuticals Company Details
    Table 112. Quark Pharmaceuticals Business Overview
    Table 113. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
    Table 114. Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 115. Quark Pharmaceuticals Recent Developments
    Table 116. Roche Company Details
    Table 117. Roche Business Overview
    Table 118. Roche RNA-Based Therapeutics and Vaccines Product
    Table 119. Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 120. Roche Recent Developments
    Table 121. Sylentis Company Details
    Table 122. Sylentis Business Overview
    Table 123. Sylentis RNA-Based Therapeutics and Vaccines Product
    Table 124. Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 125. Sylentis Recent Developments
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global RNA-Based Therapeutics and Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. RNA-Based Therapeutics Features
    Figure 3. RNA-Based Vaccines Features
    Figure 4. Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2021 VS 2028
    Figure 5. Oncology Case Studies
    Figure 6. Immunology Case Studies
    Figure 7. Ophthalmology Case Studies
    Figure 8. Cardiovascular Diseases Case Studies
    Figure 9. Infectious Diseases Case Studies
    Figure 10. Genetic Diseases Case Studies
    Figure 11. Others Case Studies
    Figure 12. RNA-Based Therapeutics and Vaccines Report Years Considered
    Figure 13. Global RNA-Based Therapeutics and Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global RNA-Based Therapeutics and Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global RNA-Based Therapeutics and Vaccines Market Share by Region: 2021 VS 2028
    Figure 16. Global RNA-Based Therapeutics and Vaccines Market Share by Players in 2021
    Figure 17. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by RNA-Based Therapeutics and Vaccines Revenue in 2021
    Figure 19. North America RNA-Based Therapeutics and Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2028)
    Figure 21. North America RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2028)
    Figure 22. North America RNA-Based Therapeutics and Vaccines Market Size Share by Country (2017-2028)
    Figure 23. United States RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe RNA-Based Therapeutics and Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2028)
    Figure 27. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2028)
    Figure 28. Europe RNA-Based Therapeutics and Vaccines Market Size Share by Country (2017-2028)
    Figure 29. Germany RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific RNA-Based Therapeutics and Vaccines Market Size Share by Region (2017-2028)
    Figure 39. China RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America RNA-Based Therapeutics and Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America RNA-Based Therapeutics and Vaccines Market Size Share by Country (2017-2028)
    Figure 49. Mexico RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa RNA-Based Therapeutics and Vaccines Market Size Share by Country (2017-2028)
    Figure 55. Turkey RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Alnylam Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 59. Arbutus Biopharma Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 60. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 61. BioNTech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 62. CureVac Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 63. Dicerna Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 64. Regulus Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 65. Marina Biotech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 66. MiRagen Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 67. Moderna Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 68. Quark Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 69. Roche Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 70. Sylentis Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
Frequently Asked Questions
RNA-Based Therapeutics and Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
RNA-Based Therapeutics and Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
RNA-Based Therapeutics and Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Roll Presses

Roll Presses market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More